Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radiation-Free MRI technique could sharpen breast calcification detection

NCT ID NCT07882147

Diagnosis Sponsor: Amal Ahmed Helmy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 20, 2026 · Last updated Oct 21, 2026 · Updated 1 time

Summary

Researchers are testing whether adding a special MRI sequence called zero echo time (ZTE) to routine breast MRI helps doctors see microcalcifications and biopsy markers more clearly. The study includes women referred for diagnostic or staging breast MRI who have a recent mammogram or a biopsy marker in place. Participants undergo standard breast MRI with the ZTE sequence added, and researchers compare the images with mammography and tissue samples to judge accuracy and image quality.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
zero echo time (ZTE) MRI sequence added to standard breast MRI
What this could lead to
If ZTE improves detection, it could give doctors a radiation-free way to see breast calcifications and biopsy markers more clearly during MRI, potentially reducing extra scans or biopsies.
What could go wrong
This is a small imaging study, and ZTE may not perform better than standard mammography or MRI for finding calcifications. Adding the sequence could lengthen scan time, and results may not apply to all breast imaging settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult women undergoing routine clinical breast MRI for suspected breast lesions, microcalcification evaluation, post-biopsy clip marker localization, or preoperative staging.

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients * Referred for diagnostic or staging breast MRI * Mammogram available within the previous 6 months, or a biopsy marker in place. * Able to provide informed consent and tolerate MRI positioning. Exclusion Criteria: * \- MRI contraindications (e.g., pacemaker or other MRI-unsafe implant, severe claustrophobia). * Pregnancy or lactation. * Contraindication to gadolinium. * Prior mastectomy or breast radiation. * Severe motion artifact

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Mri imaging

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.